XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.2
Fair Value of Financial Assets and Liabilities (Details) - Schedule of Fair Value on a Recurring Basis - Fair Value, Inputs, Level 3 [Member] - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2023
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Short-term investment at December 31, 2022 $ 13
Short-term investment at June 30, 2023 13
Notes receivable at fair value, current portion at December 31, 2022 7,474
Notes receivable at fair value, non-current portion at December 31, 2022 1,100
Collection of principal outstanding (500)
Note receivable, Convergent Therapeutics, non-current portion (500)
Unrealized loss on note receivable (212)
Accrued interest receivable 77
Notes receivable at fair value, current portion at June 30, 2023 6,339
Note receivable, Convergent Therapeutics, non-current portion 500
Accrued interest receivable 22
Notes receivable at fair value, non-current portion at June 30, 2023 $ 1,622